Benjamin F. Edwards & Company, Inc. Pulmonx Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 50 shares of LUNG stock, worth $307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$307
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$34.9 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.39 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $229M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...